2019-11-05T15:49:45-06:00 2018-12-31 454060696 CCA LLP 2300 Contra Costa Blvd Ste 220 Pleasant Hill CA 94523 990 2018-01-01 943473864 Sens Foundation Inc SENS 6503361780 110 Pioneer Way No J Mountain View CA 94041 Michael Kope President/CEO 6503361780 2019-11-05 1 CCA LLP P00587987 9256852911 2019-11-05 99.24.132.41 2019-11-05 15:49:41 PS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 11C41341E2825BA9C348AF826C977EBB3B18B533 2018 2020-01-14 16:20:31Z Sens Research Foundation Inc Michael Kope 110 Pioneer Way No J Mountain View CA 94041 8617564 0 X WWW.SENS.ORG X 2009 CA Develop, promote and ensure widespread access to rejuvenation biotechnologies. 9 8 28 10 0 0 7840321 3531916 0 0 28016 -1105802 3002 10459 7871339 2436573 1418585 720223 0 0 1393832 1542445 0 0 315463 1113258 1305591 3925675 3568259 3945664 -1131686 6675404 5306491 327923 197992 6347481 5108499 X SENS Research Foundation works to research, develop and promote comprehensive regenerative medicine solutions for the diseases and disabilities of aging. The research is governed by a strategic agenda to demonstrate the feasibility of rejuvenation biotechnologies, as a natural extension of regenerative medicine as applied to aging, and therefore drive broader involvement. 0 0 895906 The intramural research program is carried out in the Organization's Mountain View facility by employees of the Organization. The program is comprised of three (3) separate lines of research: Mitochondrial mutations, Lysosomal storage, and Immuno-senescence. The Lysosomal project is ongoing part-time at the Research Center. The Mitochondrial mutations line of research has completed proof of concept and is moving ahead with their work, presenting their findings at conferences internationally. The Immuno project was only part-time, run by the VP of Research and hosting one educational intern. 713266 602055 The extramural research program funds some of the most prestigious institutions around the world. There are currently 6 extramural research projects ongoing. Funding for this program continues to be prioritized for projects that meet our company mission and are currently being unaddressed in our intramural research program. 408310 115668 SRF Education - As part of its mission, the Organization is committed to educating students and the public about rejuvenation biotechnologies. The Organization's student program, SRF Education Academic Initiative, is committed to educating students and the public. SRF Education operates a summer internship program that places 12 undergraduate students at the SRF Research Center and outside institutions. It also began a program in 2018 to place 6 post-baccalaureate students at various institutions, including three at the SRF Research Center. A sub-program of SRF Education is the Alliance program, which funds PhD and Post-Doctoral students at Oxford University. The Education program continues to grow in size and outreach capacities. 68515 Educational Conferences - In addition to participation in a variety of scientific and public engagements, the Organization organizes its own conferences and events. These include the Undoing Aging Conference in Berlin, Germany. This outreach is intended to inform both the scientific community and the general public about damage repair strategies for improving healthcare. 646191 2500 Other programs - The Organization conducts other programs related to the mission of the organization. 714706 2500 2732188 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 23 0 1 28 1 0 0 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X The Organization 6503361780 110 Pioneer Way J Mountain View CA 94041 Barbara Logan Chairperson 4.00 X X 0 0 0 Kevin Perrott Treasurer 2.00 X X 0 0 0 Bill Liao Secretary 2.00 X X 0 0 0 Kevin Dewalt Director 1.00 X 0 0 0 Michael Boocher Director 1.00 X 0 0 0 Jonathan Cain Director 1.00 X 0 0 0 James O'Neill Director 1.00 X 0 0 0 Frank Schuler Director 1.00 X 0 0 0 Michael Kope President/CEO 40.00 X X 192851 0 5325 Aubrey de Grey Chief Science Officer 40.00 X 70931 0 0 Matthew O'Connor VP Research 40.00 X 128525 0 942 Lisa Fabiny VP Operations 40.00 X 124981 0 5463 Gregory Chin Director of Education 40.00 X 114007 0 2716 631295 0 14446 4 0 1 0 David BrindleyTranslation Ventures Limi ISIS Flat 45-53 Iffley Road Oxford UK OX41ED Contract Services 121010 1 3531916 1707710 3531916 7186 7186 5068003 6180991 -1112988 -1112988 -1112988 Miscellaneous Income 900099 10386 10386 Publication Sales 900099 4130 4130 Loss on Foreign Currency Exchange 900099 -4057 -4057 10459 2436573 10459 0 -1105802 X 461567 461567 39000 39000 219656 219656 523692 286457 109751 127484 779286 635819 60906 82561 24376 16280 3736 4360 110730 77674 10292 22764 104361 73563 13944 16854 37868 24968 12900 66708 66708 400110 303460 88047 8603 3632 1790 100 1742 8296 61 8235 241333 189886 31315 20132 83602 71623 4674 7305 95417 75657 6308 13452 44494 42500 1994 13373 13373 Bad debt expense 150000 115524 34476 Equipment and supplies 64915 64915 0 Small computer equipmen 24674 8891 14378 1405 Telephone and telecommu 13552 70 13482 0 57617 22827 25989 8801 3568259 2732188 520608 315463 1509888 4884768 2395 2141 580 519851 454978 77160 64873 5002617 272777 82764 81932 6675404 5306491 327923 197992 327923 197992 X 5766079 4702154 581402 406345 6347481 5108499 6675404 5306491 -1131686 -107296 0 X X 0 1 X 1 0 X 1650337 1429790 2684540 7840321 3531916 17136904 1650337 1429790 2684540 7840321 3531916 17136904 7358177 9778727 5600 6817 3908 28016 2478 46819 -1192 7081 5889 17189612 341285 0.56890 0.49840 X 438577 375191 63386 81274 79787 1487 64873 Crypto currency 272777 F 272777 X 2329277 -107296 -107296 2436573 0 2436573 3568259 0 3568259 0 3568259 Part X, Line 2: The Organization evaluates its uncertain tax positions and will recognize a loss contingency when it is probable that a liability has been incurred as of the date of the financial statements and the amount of the loss can be reasonably estimated. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount recognized. As of December 31, 2018, management did not identify any uncertain tax positions. 0 0 0 0 0 0 0 0 0 0 Europe Research Grant 213972 Wire 1 Contract research Research Grant 1 5684 Cash Wire 0 0 0 0 0 0 1 Yale Office of Sponsored Projects 433 Temple Street New Haven CT 06511 060646973 501c3 198478 Research grant Buck Institute for Research on Aging 8001 Redwood Blvd Novato CA 94945 943030609 501c3 117950 Research grant Applied StemCell Inc 521 Cottonwood Dr Milpitas CA 95035 262120522 107656 Research grant Sanford-Burnham Medical Research Inst 10901 N Torrey Pines Rd La Jolla CA 92037 510197108 501c3 13500 Educational research grant The Scripps Research Institute 10550 N Torrey Pines Rd La Jolla CA 92037 330435954 501c3 12000 Educational research grant Stanford University Dept of Genetics 450 Serra Mall Stanford CA 94305 941156365 501c3 7983 Educational research grant Brigham and Women's Hospital 75 Francis Street Boston MA 02115 042312909 501c3 2000 Research grant Stanford University 450 Serra Mall Stanford CA 94305 941156365 501c3 1000 Educational research grant UC Berkeley Foundation 1995 University Ave Ste 401 Berkeley CA 94704 946090626 501c3 1000 Research grant 8 1 Research grants 5 39000 Part I, Line 2: The Organization monitors grants at three month intervals. We require interim research reports every three months, which are submitted with the next payment invoice. At the conclusion of each research contract, we require a comprehensive research report and a financial accounting that details how the grant was spent. X X 0 0 0 0 0 0 0 0 0 Michael Kope President/CEO 192851 0 0 0 0 0 5325 0 0 0 198176 0 0 0 X 893 154267 FMV X Crypto currency 2258 1553443 FMV 0 0 0 Part I, Column (b): In column b, the Organization is reporting the number of units received that year. Form 990, Part VI, Section B, line 11b The form 990 is reviewed by the President and the Vice President of the Operations and presented to the Board prior to filing. Form 990, Part VI, Section B, line 12c A formal conflict of interest policy has been adopted by the organization. The policy is reviewed and reaffirmed annually. Form 990, Part VI, Section B, line 15 The president's salary was determined through the budget process by the board of directors. The board used comparable data for determining salaries of all key employees Form 990, Part VI, Section C, line 18 The forms 1023 and 990 are available at the organization's offices upon request. Form 990, Part VI, Section C, line 19 All governing documents, the conflict of interest policy and the financial statements are available at the organization's offices upon request Form 990, Part IX, line 11g Lab Services: Program service expenses 147,603. Management and general expenses 0. Fundraising expenses 0. Total expenses 147,603. Payroll Service Fees: Program service expenses 0. Management and general expenses 20,346. Fundraising expenses 0. Total expenses 20,346. Other Services: Program service expenses 155,857. Management and general expenses 67,701. Fundraising expenses 8,603. Total expenses 232,161. Form 990, Part XII, Line 2c The Organization's audit committee is charged with the responsibility of overseeing the audit and the work of the independent auditors. This process has not changed from prior years.